DDI Webinar Playback
DRUG-DRUG INTERACTION TESTING (DDI)
WOULD PATIENT CARE BE IMPROVED BY THE ABILITY TO OBJECTIVELY IDENTIFY PERTINENT DRUG INTERACTIONS?
Inconsistencies in outpatient medication records have been reported to be as high as 70% and may expose patients to harmful drug interactions. 1
Current methods of identifying drug-drug interactions (DDIs) – such as medication reconciliation, drug utilization review, and automated EMR checks – rely on subjective or self-reported patient information. Aegis offers a laboratory analysis that objectively identifies substances recently ingested by your patient that could lead to life-threatening drug interactions.
Presented by: Josh Schrecker, Pharm. D.
- Conflicting findings regarding the prevalence of drug interactions create difficulties in understanding true risk of patient harm associated with interactions.
- Deficiencies in current methods of identifying DDIs exist due to reliance on subjective drug information.
- Utilizing a targeted approach to objectively identify recently ingested substances that may cause drug interactions can improve patient care.
1 Comer D, Couto J, Aguiar R, Wu P, Elliott DJ. Usefulness of pharmacy claims for medication reconciliation in primary care. Am J Manag Care. 2015; 21(7): 486-93.